Clinical Trial Detail

NCT ID NCT03317392
Title Olaparib and Radium Ra 223 Dichloride in Treating Men With Metastatic Castration-Resistant Prostate Cancer That Has Spread to the Bone
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

prostate adenocarcinoma

Therapies

Olaparib

Age Groups: adult senior

No variant requirements are available.